NEWS & EVENTS
Optimizing NHLBI’s Clinical Trials Enterprise: Performance Milestones and Metrics Webinar
NIH
Description

NHLBI is undertaking efforts to optimize its clinical trials enterprise, and toward that end, is working with its investigator community to foster trial success and maximize the benefits of this research to society and public health.  

One area of focus is to facilitate the conduct and management of clinical trials by establishing early on clear milestones and metrics of progress through the Institute’s Funding Opportunity Announcements (FOAs) – the notices by which NHLBI solicits applications for research from its investigator community.

With extensive input from its stakeholders and advisory council, NHLBI has developed new milestone-driven FOAs for our multi-site clinical trials in Phase II and above. They are available at:

In this webinar, NHLBI will:

  • Provide an overview of NHLBI’s efforts to optimize its clinical trial enterprise, explaining how FOAs are a critical tool in that regard,
  • Describe in depth NHLBI’s new process and expectations for applications responding to NHLBI FOAs for  multi-site clinical trials in Phase II and above,
  • Discuss the specific performance milestones and metrics that NHLBI expects applicants to include in their applications for these trials, and
  • Answer investigator questions about NHLBI’s new approach, with an eye toward helping them prepare the best applications possible.  
Agenda

2:00 pm to 2:10 pm
-
Welcome and Introduction to NHLBI Efforts to Optimize its Clinical Trials Enterprise

Amy P. Patterson, M.D.

NHLBI Chief Science Advisor, and Director of Scientific Research Programs, Policy, and Strategic Initiatives

2:10 pm to 2:35 pm
-
An Overview of NHLBI’s News Funding Opportunity Announcement for Multi-site Clinical Trials (Phase II and Above)

Keary Cope, Ph.D., Scientific Review Officer, NHLBI Division of Extramural Research Activities

Simone Glynn, M.D., M.Sc., M.P.H., Branch Chief, NHLBI Division of Blood Diseases and Resources

Yves Rosenberg, M.D., M.P.H., Branch Chief, NHLBI Division of Cardiovascular Sciences

2:35 pm to 2:55 pm
-
Questions from Participants

2:55 pm to 3:00 pm
-
Next Steps and Conclusion

Amy P. Patterson, M.D.

NHLBI Chief Science Advisor, and Director of Scientific Research Programs, Policy, and Strategic Initiatives